Showing 2,676 results

Filters Content type: News, Editors' picks, About HIV Topic: Hepatitis & HIV

Hepatitis A, B and C are viral infections that can damage the liver and cause serious illnesses. Co-infection with HIV and hepatitis B or C is quite common. Safe and effective treatments are available.

New & experimental hepatitis C treatment

NICE recommends Victrelis in speedy review

Editor's pick
InPharm
9 March 2012
Hepatitis C treatment

GS-7977 plus ribavirin rapidly suppresses HCV but most patients relapse

News
7 March 2012
Hepatitis C treatment

Telaprevir and boceprevir boost sustained response rates for HIV/HCV coinfected

News
7 March 2012
Hepatitis C treatment

Hepatitis C subtype-1b and carriage of IL28B gene associated with improved treatment responses in HIV-co-infected patients

News
1 March 2012
Hepatitis C treatment

Copy of Cholesterol-Reducing Statins, Other Meds to Be Avoided With Hep C Protease Inhibitors

Editor's pick
Kaiser Daily Global Health Policy Report
1 March 2012
Hepatitis C treatment

Cholesterol-Reducing Statins, Other Meds to Be Avoided With Hep C Protease Inhibitors

Editor's pick
AIDSMeds
1 March 2012
Hepatitis & HIV

HIV treatment isn't a risk factor for liver dysfunction, but HIV infection is

News
29 February 2012
New & experimental hepatitis C treatment

Good 12-Week HCV Suppression with Oral Telaprevir/VX-222/Ribavirin Combo

Editor's pick
HIVandHepatitis.com
27 February 2012
Hepatitis C treatment

Hepatitis C protease inhibitor therapy cost-effective in some circumstances

News
21 February 2012
Hepatitis C symptoms & diagnosis

Hepatitis C surpasses HIV as a cause of death in the US

News
21 February 2012
New & experimental hepatitis C treatment

HCAB position statement: Hepatitis C drug development and drug-drug interaction studies

Editor's pick
EATG
18 February 2012
New & experimental hepatitis C treatment

European Medicines Agency informs doctors and patients about drug interaction between Victrelis and ritonavir-boosted HIV protease inhibitors

Editor's pick
European Medicines Agency
18 February 2012
New & experimental hepatitis C treatment

Hard-to-Treat Group Trips Up Hepatitis C Drug

Editor's pick
MedPage Today
18 February 2012
New & experimental hepatitis C treatment

Gilead Announces Data for Genotype 1 Null Responder Hepatitis C Patients Enrolled in ELECTRON Study

Editor's pick
Gilead press release
17 February 2012
New & experimental hepatitis C treatment

Gilead Drops as Patients Relapse on Hepatitis C Drug

Editor's pick
Bloomberg Business Week
17 February 2012
New & experimental hepatitis C treatment

Drugmakers Jockey for Piece of Future Hepatitis C Combo Pill

Editor's pick
Bloomberg Business Week
15 February 2012
Hepatitis C transmission & prevention

Hepatitis C Survival on Inanimate Objects

Editor's pick
Hepatitis Central
14 February 2012
New & experimental hepatitis C treatment

Gilead, Vertex and the Mystery of Missing Hep C Patients

Editor's pick
The Street
13 February 2012
Hepatitis C transmission & prevention

Professional tattooing in sterile environment not associated with risk of hepatitis C

News
8 February 2012
Hepatitis C treatment

Merck Warns of Victrelis and HIV Protease Inhibitor Interactions

Editor's pick
AIDSMeds
8 February 2012
Hepatitis C treatment

Copy of Merck Warns of Victrelis and HIV Protease Inhibitor Interactions

Editor's pick
Kaiser Daily Global Health Policy Report
8 February 2012
Drug interactions & pharmacokinetics

Combining HCV Med Boceprevir with Boosted HIV Protease Inhibitors Can Lower Drug Levels

Editor's pick
HIVandHepatitis.com
7 February 2012
New & experimental hepatitis C treatment

Gilead Gains on Positive Data From Experimental Hepatitis C Drug

Editor's pick
Bloomberg
3 February 2012
Hepatitis C treatment

European Study Does Not See Rapid Long-Term Liver Fibrosis in HIV/HCV Coinfected People

Editor's pick
HIVandHepatitis.com
2 February 2012